Brief Reports
Copyright ©The Author(s) 2000.
World J Gastroenterol. Feb 15, 2000; 6(1): 140-142
Published online Feb 15, 2000. doi: 10.3748/wjg.v6.i1.140
Table 1 Antitumoral activity of LDL-ACM complex and free ACM agains t murine subcutaneous H22 tumor
DrugsMean weight change (g)Tumor weight (-x ± s, g)Inhibition rate (%)
Control+ 5.41.74 ± 0.60
Free ACM+ 3.21.30 ± 0.5725.3
LDL-ACM+ 3.50.86 ± 0.4450.2
Table 2 Antitumoral activity of LDL-ACM complex and free ACM agains t murine intraperitoneal H22 tumor
DrugsSurvival time (-x ± s, d)Life-prolonging rate (%)
Control17.1 ± 3.44
Free ACM24.6 ± 7.5043.9
LDL-ACM33.4 ± 7.6795.3